Press Release

Molecular Partners to Present at the 17th Annual Meeting of Bio€quity Europe 2016 in Copenhagen

Zurich-Schlieren, May 09, 2016. Molecular Partners AG (ticker: MOLN) today announced that it will present at the 17^thAnnual Meeting of Bio€quity Europe in Copenhagen on Tuesday, May 10, 2016 at 2:00 PM CET. The presentation will be hosted by Dr. Patrick Amstutz, COO of Molecular Partners.

A copy of the presentation handout will be made available on the company’s website www.molecularpartners.com under the Investors section.

About Molecular Partners AG

Molecular Partners AG is a clinical-stage biopharmaceutical company that is developing a new, class of therapies known as DARPins. DARPins are potent, specific, and versatile small-protein therapies, which have the potential to offer benefits over conventional monoclonal antibodies or other currently available protein therapeutics. The DARPin technology has the potential to offer a multi-specific approach to treatment, which enables DARPins to target multiple pathways, or multiple epitopes on a single target to achieve substantial patient benefit. DARPins have the potential to advance modern medicine and significantly improve the treatment of serious diseases, including cancer and sight-threatening disorders.

Molecular Partners has four compounds in various stages of clinical and preclinical development and several more in the research stage, with a current focus on ophthalmology and oncology. The company has ongoing research and development partnerships with leading pharmaceutical companies, including Allergan and Janssen, and is backed by established biotech investors. For more information regarding Molecular Partners AG, go to: www.molecularpartners.com.

For further details, please contact:

Dr. Christian Zahnd, CEO
christian.zahnd@molecularpartners.com
Tel: +41 (0) 44 755 77 00

Andreas Emmenegger, CFO
andreas.emmenegger@molecularpartners.com
Tel: +41 (0) 44 755 77 00

Rolf Schläpfer
Hirzel.Neef.Schmid.Counselors
rolf.schlaepfer@konsulenten.ch
Tel: +41 (0) 43 344 42 42

Cookie	Duration	Description
__AntiXsrfToken	session	This cookie is used to prevent cross-scripting attacks. It holds a session to verify the login sessions.
ASP.NET_SessionId	session	Issued by Microsoft's ASP.NET Application, this cookie stores session data during a user's website visit.
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
JSESSIONID	session	The JSESSIONID cookie is used by New Relic to store a session identifier so that New Relic can monitor session counts for an application.
nlbi_1917628	session	A load balancing cookie set to ensure requests by a client are sent to the same origin server.
nlbi_1917631	session	A load balancing cookie set to ensure requests by a client are sent to the same origin server.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
visid_incap_1917628	1 year	SiteLock sets this cookie to provide cloud-based website security services.
visid_incap_1917631	1 year	SiteLock sets this cookie to provide cloud-based website security services.

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
s_cc	session	This cookie is set by Adobe Analytics to determine if cookies are enabled or not.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_138254728_1	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
demdex	5 months 27 days	The demdex cookie, set under the domain demdex.net, is used by Adobe Audience Manager to help identify a unique visitor across domains.

Cookie	Duration	Description
AMCV_98CF678254E93B1B0A4C98A5AdobeOrg	2 years	No description
AMCVS_98CF678254E93B1B0A4C98A5AdobeOrg	session	No description
BIGipServerREC_PRD_FO_CH	session	No description
DrupalVisitorMobile	session	No description available.
GNWTracker	past	No description available.
GNWUserSessionId	past	No description available.
incap_ses_452_1917628	session	No description
incap_ses_452_1917631	session	No description
MQAB	2 months	No description
psession	1 year	No description
rflex_cookie	session	No description available.
TEST_AMCV_COOKIE_WRITE	session	No description
ts_sessionid	session	No description
tsession	session	No description